健康经济学如何用于适应性临床试验的设计与分析:一项定性分析
该定性研究通过访谈和焦点小组(29名参与者)探讨了研究者、决策者和公众对在适应性临床试验设计与分析中使用健康经济学的看法。参与者认为临床试验应优先回答临床研究问题,同时提出了中期分析中成本数据波动性、全球试验实施、资源投入和培训等顾虑。结论认为健康经济学在此类试验中的应用有望提升卫生技术评估效率,并给出了方法开发与实践实施建议。
要点
- 临床试验应优先回答临床研究问题,成本-效果对决策亦重要。
- 中期分析中成本数据波动性是应用健康经济学的主要顾虑之一。
- 需开发方法并培训利益相关者以支持健康经济学在适应性试验中的实施。
核心结论
- 在适应性临床试验设计与分析中应用健康经济学有望提高全球卫生技术评估的效率。
研究设计与样本
- 定性研究,通过访谈和焦点小组收集29名参与者(包括研究者、决策者和公众成员)的数据,采用框架分析识别主题。
主要发现
- 参与者认为临床试验应优先回答临床研究问题,尽管成本-效果对决策很重要。
- 参与者提出的顾虑包括中期分析中成本数据的波动性、在全球试验中实施该方法、为基于健康经济结果设计和调整的适应性试验提供资源,以及培训利益相关者以实施和正确解读这些方法。
临床怎么用
- 建议开发方法以允许在适应性临床试验中使用健康经济学,并给出促进实践实施的建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adaptive designs offer a flexible approach, allowing changes to a trial based on examinations of the data as it progresses. Adaptive clinical trials are becoming a popular choice, as the prudent use of finite research budgets and accurate decision-making are priorities for healthcare providers around the world. The methods of health economics, which aim to maximise the health gained for money spent, could be incorporated into the design and analysis of adaptive clinical trials to make them more efficient. We aimed to understand the perspectives of stakeholders in health technology assessments to inform recommendations for the use of health economics in adaptive clinical trials. METHODS: A qualitative study explored the attitudes of key stakeholders-including researchers, decision-makers and members of the public-towards the use of health economics in the design and analysis of adaptive clinical trials. Data were collected using interviews and focus groups (29 participants). A framework analysis was used to identify themes in the transcripts. RESULTS: It was considered that answering the clinical research question should be the priority in a clinical trial, notwithstanding the importance of cost-effectiveness for decision-making. Concerns raised by participants included handling the volatile nature of cost data at interim analyses; implementing this approach in global trials; resourcing adaptive trials which are designed and adapted based on health economic outcomes; and training stakeholders in these methods so that they can be implemented and appropriately interpreted. CONCLUSION: The use of health economics in the design and analysis of adaptive clinical trials has the potential to increase the efficiency of health technology assessments worldwide. Recommendations are made concerning the development of methods allowing the use of health economics in adaptive clinical trials, and suggestions are given to facilitate their implementation in practice.
引用
- Flight L, Julious S, Brennan A, et al. How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis. Trials. 2020. PMID: 32143728. doi:10.1186/s13063-020-4137-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。